Ilya Yuffa Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 days, 2 hours ago
Ilya Yuffa has an estimated net worth of at least $39.5 million*, as of June 10, 2026. They own 29,804 shares of LLY stock. They have sold 7,000 shares of LLY stock since 2021, for an estimated $2.2 million.
Ilya Yuffa $LLY SEC Form 4 Insider Trading
Ilya Yuffa has filed a total of 5 insider trades in $LLY since 2021. Their most recent trade was a sale of 2,500 shares, made on Jun 10, 2026. Their largest trade was a sale of 2,500 shares, made on Jun 10, 2026. We estimate that they now own 29,804 shares of $LLY, worth an estimated $37.3 million.
Insider Trading at $LLY
There have been a total of 1019 insider trades reported at $LLY since 2021, with 7,845 shares purchased and 16.8 million shares sold. The most active insider traders in $LLY stock have been Donald A Zakrowski, Daniel Skovronsky, and Alonzo Weems. The most recent trade was a sale of 2,500 shares reported by Ilya Yuffa (EVP&Pres, LLY USA&Global Capab), made on Jun 10, 2026.
History of Insider Stock Trades by Ilya Yuffa
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
LLY
|
Sale | 2,500 | Jun 10, 2026 | June 11, 2026, 4:23 p.m. |
|
LLY
|
Sale | 1,250 | Aug 11, 2025 | Aug. 12, 2025, 4:16 p.m. |
|
LLY
|
Sale | 1,250 | May 14, 2025 | May 15, 2025, 4:17 p.m. |
|
LLY
|
Sale | 1,000 | Feb 15, 2022 | Feb. 17, 2022, 5:40 p.m. |
|
LLY
|
Sale | 1,000 | Feb 16, 2022 | Feb. 17, 2022, 5:40 p.m. |
$LLY Executives and Stock Owners with Insider Trades
-
Donald A Zakrowski, SVP, Finance, & CAO
-
Daniel Skovronsky, EVP, CSO & Pres. LRL & LLY Imm
-
Alonzo Weems, EVP, ERM & CECO
-
Donald A Zakrowski, Chief Accounting Officer
-
Johna Norton, EVP, Global Quality
-
Anne E. White, EVP & Pres, Lilly Neuroscience
-
Ilya Yuffa, EVP&Pres, LLY USA&Global Capab
-
Ilya Yuffa, SVP & President, LLY Int'l
-
Patrik Jonsson, SVP&Pres, LLY Imm, LLY USA&CCO
-
Alonzo Weems, SVP, ERM & CECO
-
David A Ricks, President, Chair, and CEO
-
Ilya Yuffa, EVP & President, LLY Int'l
-
Lucas Montarce, EVP & CFO
-
Naarden Jacob Van, EVP & Pres., Lilly Oncology
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.